Stablecoin issuer Circle's stock skyrocketed out of the gate, beating the initial public markets performance of tech giants.

RxSight offers strong growth potential in cataract treatment, with scalable tech, a large market, and attractive valuation.

Palantir's meteoric rise since its direct listing in 2020 has transformed the once-secretive government contractor into a ...

Booking Holdings' growth is slowing, with choppy bookings trends and decelerating revenue. Click here to find out why I ...

The second-day trading gain of about 45% for Circle's newly issued stock puts it many times over the average second-day return for larger IPOs over the past five years, according to Jay Ritter, a ...

Asset managers in Brazil are ramping up to take full advantage of a comeback in local equities after long stretches of weak ...

More specifically, the market witnessed two of the wildest moves in the benchmark S&P 500 during a one-week span. Between the ...

From Chinese manufacturers to French jet makers, ThePrint looks at how the 88-hour India-Pakistan standoff sent ripples ...

Q1 2025 Earnings Call Transcript June 5, 2025 Petco Health and Wellness Company, Inc. beats earnings expectations. Reported ...

This press release does not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall ...

Small-caps have underperformed large-caps for 12 years now, which means they’re very cheap and, as BofA notes, good in a ...

Above Food Ingredients Inc. ("the Company"), acknowledges receipt of a formal notification from The Nasdaq Stock Market LLC ...